Under a Mobile Service Provider (MSP) agreement, CLS supplies its FDA-cleared 510(k) TRANBERG heat therapy system in a combined service offering, with consumable accessories, training, and on-site clinical and technical staff support for physician and staff procedures. .
In the United States, more than one million prostate biopsies are performed annually, leading to the diagnosis of prostate cancer in approximately 250,000 men. Focal laser ablation of prostate tumors has demonstrated high degrees of precision and accuracy with a low risk of side effects. such as erectile disorder and urinary incontinence.
“We are excited to offer our TRANBERG formula to cutting-edge urologists looking to incorporate focal laser ablation into their practice without having to incur capital expenditures,” said Michael Magnani, president of CLS Americas. “Our TRANBERG formula is commercially available to U. S. urologists. U. S. and clinics wishing to treat patients with low- to intermediate-risk prostate cancer in a workplace or outpatient clinic. “
TRANBERG™Thermal Therapy System The TRANBERG Thermal Therapy System can be configured for MRI/US fusion-guided procedures and real-time tissue temperature measurements for accurate treatment and ablation control. It includes a desktop cellular laser unit, state-of-the-art uncooled laser applicators, tissue temperature probes and procedure-specific accessories. The TRANBERG formula can be implemented transperineally or transrectally. The TRANBERG System is 510(k) cleared for the ablation of soft tissues, such as the prostate.
About CLS Americas Clinical Laserthermia Systems Americas Inc. , founded in Irvine, California, is responsible for the sales, business development, operations and clinic of the TRANBERG™ heat therapy system and its accessories for the U. S. urology market. UU. La rugged formula allows for minimally invasive, high-precision focal laser ablation therapy that employs MR or MR US Fusion for symbol direction and has obtained 510(k) clearance from the FDA in the U. S. The U. S. Department of Disease and Drug Administration is used to ablate soft tissues, such as prostate tumors.
CLS Americas is a subsidiary of Clinical Laserthermia Systems AB (publ) headquartered in Lund, Sweden, with subsidiaries in Germany, the United States and Singapore. For more information about CLS, visit the company’s website: www. clinicallaser. com. Contact CLS Americas : Phone: 1 (949) 504-5440, Email: contact-us@clinicallaser. com.